Spherocytosis, Type 2; Sph2
Description
Hereditary spherocytosis refers to a group of heterogeneous disorders that are characterized by the presence of spherical-shaped erythrocytes (spherocytes) on the peripheral blood smear. The disorders are characterized clinically by anemia, jaundice, and splenomegaly, with variable severity. Common complications include cholelithiasis, hemolytic episodes, and aplastic crises (review by Perrotta et al., 2008).For a general description and a discussion of genetic heterogeneity of hereditary spherocytosis, see {182900}.
Clinical Features
Phenotypes and symptoms related to Spherocytosis, Type 2; Sph2
- Anemia
- Splenomegaly
- Jaundice
- Hemolytic anemia
- Hyperbilirubinemia
- Cholelithiasis
- Reticulocytosis
- Acanthocytosis
- Spherocytosis
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Spherocytosis, Type 2; Sph2 Is also known as hs2, spherocytosis, hereditary, 2.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Spherocytosis, Type 2; Sph2 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Red Blood Cell Membrane Disorders panel by next-generation sequencing (NGS).
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
RHAG, SLC2A1, SPTA1, SPTB, XK, ATP11C, ABCG5, ABCG8, COL4A1, PIEZO1, EPB41, EPB42, GYPC, ANK1, KCNN4
Specificity
7 %
Genes
100 % |
Hemolytic Anemia Panel by next-generation sequencing (NGS).
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
RHAG, SEC23B, SLC2A1, SPTA1, SPTB, TPI1, XK, ATP11C, ABCG5, ABCG8, LPIN2, CDAN1, NT5C3A, COL4A1, C15orf41, PIEZO1, EPB41, EPB42, AK1, ALAS2 , (...)
View the complete list with 16 more genes
Specificity
3 %
Genes
100 % |
SPTB Sequencing.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
SPTB
Specificity
100 %
Genes
100 % |
SPTB Deletion/duplication analysis.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
SPTB
Specificity
100 %
Genes
100 % |
Hemolytic Anemia Deletion/Duplication Panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
RHAG, SEC23B, SLC2A1, SPTA1, SPTB, TPI1, XK, ABCG5, ABCG8, LPIN2, CDAN1, NT5C3A, C15orf41, PIEZO1, EPB41, EPB42, AK1, G6PD, ALDOA, GATA1 , (...)
View the complete list with 12 more genes
Specificity
4 %
Genes
100 % |
Red Blood Cell Membrane Disorders Deletion/Duplication Panel.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
RHAG, SLC2A1, SPTA1, SPTB, XK, ABCG5, ABCG8, PIEZO1, EPB41, EPB42, GYPC, ANK1
Specificity
9 %
Genes
100 % |
Hereditary Hemolytic Anemia Panel, Sequencing.
By ARUP Laboratories, Molecular Genetics and Genomics (United States).
SLCO1B1, SLCO1B3, SPTA1, SPTB, TPI1, UGT1A1, UGT1A6, UGT1A7, NT5C3A, ADA, CYB5R3, PIEZO1, EPB41, EPB42, AK1, G6PD, ALDOA, GCLC, GPI, GSS , (...)
View the complete list with 6 more genes
Specificity
4 %
Genes
100 % |
SPTB. Complete sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
SPTB
Specificity
100 %
Genes
100 % |
You can get up to 36 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like NEUROFIBROMATOSIS, TYPE I; NF1 HURLER-SCHEIE SYNDROME MICROPHTHALMIA WITH LIMB ANOMALIES; MLA FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1 BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2 BRUGADA SYNDROME 6; BRGDA6